Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial
Authors
Keywords
-
Journal
STROKE
Volume 53, Issue 11, Pages 3250-3259
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-09-06
DOI
10.1161/strokeaha.122.039649
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
- (2020) Michael D Hill et al. LANCET
- Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial
- (2018) Ji Man Hong et al. Trials
- Impact of varying levels of hyperglycemia on clinicoradiographic outcomes after endovascular reperfusion treatment
- (2018) Seong-Joon Lee et al. Scientific Reports
- Neuroprotectants in the Era of Reperfusion Therapy
- (2018) Ángel Chamorro Journal of Stroke
- Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort
- (2016) E. Osei et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
- (2016) Mayank Goyal et al. LANCET
- Endovascular Thrombectomy for Acute Ischemic Stroke
- (2015) Jetan H. Badhiwala et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
- (2015) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
- (2015) Mayank Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
- (2015) Olvert A. Berkhemer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Animal models of ischemic stroke and their application in clinical research
- (2015) Christoph Kleinschnitz et al. Drug Design Development and Therapy
- Choosing a Hyperacute Stroke Imaging Protocol for Proper Patient Selection and Time Efficient Endovascular Treatment: Lessons from Recent Trials
- (2015) Jin Soo Lee et al. Journal of Stroke
- Therapeutic Hypothermia After Recanalization in Patients With Acute Ischemic Stroke
- (2013) Ji Man Hong et al. STROKE
- Role of the NMDA receptor and iron on free radical production and brain damage following transient middle cerebral artery occlusion
- (2012) Doo Soon Im et al. BRAIN RESEARCH
- Antioxidant properties of Neu2000 on mitochondrial free radicals and oxidative damage
- (2012) Nishant P. Visavadiya et al. TOXICOLOGY IN VITRO
- Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats
- (2011) Sun Mi Won et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat
- (2010) Ui Jin Park et al. ACTA NEUROPATHOLOGICA
- Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke
- (2010) S.J. Cho et al. DRUG NEWS & PERSPECTIVES
- Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
- (2010) Nyika D. Kruyt et al. Nature Reviews Neurology
- Comparison of Telephone and Face-to-Face Assessment of the Modified Rankin Scale
- (2009) Paula M. Janssen et al. CEREBROVASCULAR DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now